Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02565498 · ClinicalTrials.gov registry record · Phase 3
Preoperative vs Postoperative IMRT for Extremity/Truncal STS
A Phase 3 study of Adult Soft Tissue Sarcoma, sponsored by Mount Sinai Hospital, Canada.
- Active
- Registry status
- Phase 3
- Development phase
- 210
- Enrollment target
- 8
- Study locations
NCT02565498 is a Phase 3 study of Adult Soft Tissue Sarcoma that is active but no longer recruiting, run by Mount Sinai Hospital, Canada. The registered enrollment target is 210 participants. The trial reports 8 study locations across 6 states.
The verdict
NCT02565498, a Phase 3 study of Adult Soft Tissue Sarcoma, is active but no longer recruiting, sponsored by Mount Sinai Hospital, Canada.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 3
- Development phase
- 210 participants
- Enrollment target
- 8
- Study locations
Study Summary
This study is designed to determine if preoperative image guided radiation therapy (IGRT) delivered using intensity modulated radiation therapy (IMRT) followed by surgery results in similar short-term wound healing complications as surgery followed by postoperative IGRT in patients with extremity or truncal soft tissue sarcoma. Half of the patients will receive preoperative radiotherapy, half will receive postoperative radiotherapy.
Conditions Studied
Interventions
- RADIATION Preoperative intensity modulated radiation therapy
- RADIATION Postoperative intensity modulated radiation therapy
Study Locations (8)
Ontario
- The Ottawa Hospital Cancer Centre - Ottawa
- Mount Sinai Hospital - Toronto
- Princess Margaret Cancer Centre - Toronto
Massachusetts
- Dana Farber Cancer Institute - Boston
Ohio
- Cleveland Clinic Taussig Cancer Institute - Cleveland
Oregon
- Oregon Health & Science University - Portland
Other
- Cliniques Universitaires Saint-Luc - Brussels
Quebec
- Hopital Maisonneuve-Rosemont - Montreal
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 210 participants |
| Start Date | 2016-06 |
| Est. Completion | 2029-05 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02565498
The ClinicalTrials.gov registry entry for NCT02565498 describes a study currently listed as active not recruiting, categorized as Phase 3. The registered enrollment target is 210 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mount Sinai Hospital, Canada, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Adult Soft Tissue Sarcoma appearing as the primary indexed condition, and to 2 interventions - of which Preoperative intensity modulated radiation therapy is the first listed.
NCT02565498 reports 8 study locations spanning 6 distinct geographic areas - top geographies include Ontario, Massachusetts, Ohio.
Frequently Asked Questions
What is clinical trial NCT02565498 about?
NCT02565498 is a clinical study titled "Preoperative vs Postoperative IMRT for Extremity/Truncal STS". This study is designed to determine if preoperative image guided radiation therapy (IGRT) delivered using intensity modulated radiation therapy (IMRT) followed by surgery results in similar short-term wound healing complications as surgery followed by postoperative IGRT in patients with extremity or...
What is the current status of trial NCT02565498?
This trial is currently active not recruiting. It is a Phase 3 study. The enrollment target is 210 participants. The study started on 2016-06. Estimated completion is 2029-05.
What conditions does trial NCT02565498 study?
This clinical trial studies the following conditions: Adult Soft Tissue Sarcoma.
What interventions are being tested in trial NCT02565498?
The interventions under investigation include: Preoperative intensity modulated radiation therapy (RADIATION), Postoperative intensity modulated radiation therapy (RADIATION).
Who is sponsoring clinical trial NCT02565498?
This trial is sponsored by Mount Sinai Hospital, Canada, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02565498 being conducted?
This trial has 8 study locations across Massachusetts, Ohio, Oregon, Ontario, Quebec. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.